ABVC
Abvc Biopharma, Inc.Company with tickers: ABVC
CIK
1173313
CUSIP
00091F304
Shares Outstanding
26,000,442
13F Activity (30d)
12 filings
12 filers
Price
$1.29
Market Cap
$33.54M
P/E Ratio
-3.07
EPS (Diluted)
$-0.42
52W High
$5.48
52W Low
$0.88
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $693,005 | USD | 2025-03-31 | 10-Q | 2026-05-18 |
| Research & Development | $28,861 | USD | 2025-03-31 | 10-Q | 2026-05-18 |
| Operating Income | $-693,005 | USD | 2025-03-31 | 10-Q | 2026-05-18 |
| Net Income | $-842,075 | USD | 2025-03-31 | 10-Q | 2026-05-18 |
| EPS (Basic) | $-0.06 | USD/shares | 2025-03-31 | 10-Q | 2026-05-18 |
| EPS (Diluted) | $-0.06 | USD/shares | 2025-03-31 | 10-Q | 2026-05-18 |